• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

SonoSite gains Japanese distributor

Article

Handheld ultrasound developer SonoSite continues to expand its distribution opportunities in Asia. After establishing a subsidiary in Hong Kong and a branch office in Shanghai last month to provide direct sales and support for its products to the

Handheld ultrasound developer SonoSite continues to expand its distribution opportunities in Asia. After establishing a subsidiary in Hong Kong and a branch office in Shanghai last month to provide direct sales and support for its products to the People’s Republic of China (SCAN 9/1/99), Bothell, WA-based SonoSite has now signed an agreement with Olympus Optical for rights to distribute the ultrasound devices in Japan. Tokyo-based Olympus’s Medical Products Group markets and distributes medical endoscopes, clinical analyzers, and other advanced medical equipment. With the signing of this agreement, SonoSite has finalized arrangements to sell and distribute products in more than 75 countries through international distributors.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.